Misleading omission?, page-4

vango - Quite so - "at the request of the applicant" !
What is presented by TIS management to the ASX is the sanitized version of the meaning contained in the relevant EMEA document.   
This is not the first time - see my prev post 14476788
October CHMP Meeting (EMEA/H/D/002831), ((substance to be reviewed) insulin-like growth factor-i (igf-i) segment), (hard-to-heal wounds, primarily venous leg ulcers) List of Questions adopted on 23.01.2014. List of Outstanding Issues adopted on 25.09.2014. • Request from the applicant for an additional extension of clock stop to respond to the List of Outstanding Issues adopted in September 2014: For adoption.
The applicant for the extension of the clock stop was TIS and not the EMA nor the BIS.

athertonlady - our experts are led by Dr. G. Shooter, a QUT(and part-time TIS) employee, and his team.